Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2022-07-07 Annual Report
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
111年年報及股東會資料 — 2022_1786_20220629F13.pdf
Annual Report Classification · 95% confidence The document is a detailed agenda and materials for the 111th Annual General Meeting (AGM) of Scivision Biotech Inc., including the meeting procedures, reports, approval items, discussion items, and attachments such as the 110th fiscal year business report, audit committee report, auditor's reports, individual and consolidated financial statements, and profit distribution plan. The presence of the full business report, audit reports, and financial statements indicates this is the actual Annual Report content presented at the AGM, not just an announcement or summary. The document length is substantial (15,000 characters), and it contains comprehensive financial data and management discussion. Therefore, it fits the definition of an Annual Report (10-K). FY 2021
2022-07-07 Chinese
111年年報及股東會資料 — 2022_1786_20220629F02.pdf
Annual Report Classification · 95% confidence The document is a detailed agenda and materials for the 111th Annual General Meeting (AGM) of Scivision Biotech Inc., including the meeting procedures, reports, approval items, discussion items, and attachments such as the 110th fiscal year business report, audit committee report, auditor's reports, individual and consolidated financial statements, and profit distribution plan. The presence of the full business report, audit reports, and financial statements within the document indicates it is the actual Annual Report content presented at the AGM, not just an announcement or summary. The document length is substantial (15,000 characters), and it contains comprehensive financial data and management reports. Therefore, the document fits the definition of an Annual Report (10-K) rather than an AGM Information (AGM-R) or Report Publication Announcement (RPA). FY 2021
2022-07-07 Chinese
111年年報及股東會資料 — 2022_1786_20220629FE1.pdf
AGM Information Classification · 95% confidence The document is titled 'Notice of 2022 Annual General Shareholders’ Meeting' and details the agenda items for the meeting, including reporting items, approval items, discussion items, and extraordinary motions. It includes information about the meeting date, location, and proposals such as dividend distribution and amendments to company regulations. The document is a notice or announcement about the AGM rather than the actual AGM materials or reports themselves. The length is short (1711 characters), and it serves to inform shareholders about the meeting and agenda, not to present detailed financial data or reports. Therefore, it fits the category of AGM Information (AGM-R).
2022-07-07 Chinese
111年年報及股東會資料 — 2022_1786_20220629F01.pdf
AGM Information Classification · 100% confidence The document is a detailed notice and related materials for the 111th Annual General Meeting (AGM) of 科妍生物科技股份有限公司, including the meeting agenda, proxy forms, dividend distribution proposal, and instructions for shareholders. It contains no financial statements or management discussion but focuses on the logistics and procedural information for the AGM. The presence of proxy forms, meeting agenda, voting instructions, and shareholder meeting logistics clearly identifies this as AGM Information. The document length is about 5700 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-07-07 Chinese
111年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (科妍) providing information about fund loans and endorsement guarantees for the current and previous month, with amounts stated as zero. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of routine compliance filings. The document is short (601 characters) and does not contain comprehensive financial statements or detailed analysis. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement of financial information, best classified under Regulatory Filings (RNS).
2022-07-07 Chinese
111年6月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍 for the period 民國111年06月 (June 2022). It includes comparative figures from the previous year and percentage changes. The content is brief (764 characters) and primarily numerical data without detailed financial statements or management discussion. It does not contain a full annual or interim report, nor does it announce or attach a report. It is a periodic financial data disclosure, typical of an Interim / Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. Therefore, the document fits best under the Interim / Quarterly Report (IR) category. H1 2022
2022-07-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.